Market Cap 58.35M
Revenue (ttm) 0.00
Net Income (ttm) -80.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,471,300
Avg Vol 4,198,450
Day's Range N/A - N/A
Shares Out 172.12M
Stochastic %K 53%
Beta 0.51
Analysts Strong Buy
Price Target N/A

Company Profile

Renovaro Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands. It operates through two segments, RENB and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an art...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 918 1980
Address:
2080 Century Park East, Suite 906, Los Angeles, United States
Stengaard1
Stengaard1 Jul. 17 at 10:32 PM
$RENB I think it is fair to say that no good deed goes unpunished - especially for $RENB - in the paper it is said - quote: 5. Conclusions Our data shows the therapeutic efficacy of engineered DCs in preclinical humanized mouse models bearing pancreatic tumors. This approach could offer an off-the-shelf treatment for solid tumors in the future. This allogeneic DC platform could overcome cancer immune suppression, induce long-lasting memory for surveillance, and inhibit tumor recurrence. Furthermore, our proposed engineered allogeneic DC platform can potentially be combined with other therapeutic modalities such as checkpoint inhibitor combinations, targeted radioligand therapies, and standard-of-care chemotherapy as a therapeutic modality for the treatment of hard-to-treat cancers [47,75]. How on earth this goes virtually unnoticed is beyond me...
0 · Reply
Yassin_tet
Yassin_tet Jul. 17 at 7:29 PM
$RENB MAN !!!!
0 · Reply
jennifer45
jennifer45 Jul. 17 at 3:26 PM
$RENB Lets go!
1 · Reply
paok44
paok44 Jul. 17 at 2:23 PM
$RENB will close up today 5%+
0 · Reply
1dk2la
1dk2la Jul. 17 at 1:52 PM
0 · Reply
Stengaard1
Stengaard1 Jul. 17 at 1:47 PM
$RENB worldclass results !!! https://www.newswire.com/news/peer-reviewed-study-validates-renovaros-genetically-engineered-dendritic-cell
2 · Reply
fishmedic
fishmedic Jul. 17 at 1:35 PM
$RENB this price action gives me heartburn.
0 · Reply
DARKP00L
DARKP00L Jul. 17 at 1:24 PM
$RENB momentum building! Stock attracting attention, could be a mover!
0 · Reply
ATerragna
ATerragna Jul. 17 at 1:19 PM
$RENB Is this ready?
0 · Reply
Marketmoverjoe
Marketmoverjoe Jul. 17 at 10:01 AM
$RENB of course I sold yesterday when they were up 6% and it runs to 23% Tired of watching this thing go up and down. Go get em, boyz.
0 · Reply
Latest News on RENB
Renovaro Announces $15 million in Equity Committed

Feb 26, 2025, 9:15 AM EST - 5 months ago

Renovaro Announces $15 million in Equity Committed


Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Jan 7, 2025, 9:15 AM EST - 6 months ago

Renovaro Appoints Nathen Fuentes as Chief Financial Officer


Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Dec 30, 2024, 9:00 AM EST - 7 months ago

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV


Renovaro Regains Compliance with NASDAQ Listing Requirement

Dec 20, 2024, 3:40 PM EST - 7 months ago

Renovaro Regains Compliance with NASDAQ Listing Requirement


RenovaroCube Announces Strategic Offering of Up to 20% Ownership

Sep 11, 2024, 9:15 AM EDT - 11 months ago

RenovaroCube Announces Strategic Offering of Up to 20% Ownership


Renovaro, Inc. Announces $10 million in Equity Committed

Jun 14, 2024, 9:06 AM EDT - 1 year ago

Renovaro, Inc. Announces $10 million in Equity Committed


Statement of Renovaro Inc

Feb 14, 2024, 10:01 AM EST - 1 year ago

Statement of Renovaro Inc


Stengaard1
Stengaard1 Jul. 17 at 10:32 PM
$RENB I think it is fair to say that no good deed goes unpunished - especially for $RENB - in the paper it is said - quote: 5. Conclusions Our data shows the therapeutic efficacy of engineered DCs in preclinical humanized mouse models bearing pancreatic tumors. This approach could offer an off-the-shelf treatment for solid tumors in the future. This allogeneic DC platform could overcome cancer immune suppression, induce long-lasting memory for surveillance, and inhibit tumor recurrence. Furthermore, our proposed engineered allogeneic DC platform can potentially be combined with other therapeutic modalities such as checkpoint inhibitor combinations, targeted radioligand therapies, and standard-of-care chemotherapy as a therapeutic modality for the treatment of hard-to-treat cancers [47,75]. How on earth this goes virtually unnoticed is beyond me...
0 · Reply
Yassin_tet
Yassin_tet Jul. 17 at 7:29 PM
$RENB MAN !!!!
0 · Reply
jennifer45
jennifer45 Jul. 17 at 3:26 PM
$RENB Lets go!
1 · Reply
paok44
paok44 Jul. 17 at 2:23 PM
$RENB will close up today 5%+
0 · Reply
1dk2la
1dk2la Jul. 17 at 1:52 PM
0 · Reply
Stengaard1
Stengaard1 Jul. 17 at 1:47 PM
$RENB worldclass results !!! https://www.newswire.com/news/peer-reviewed-study-validates-renovaros-genetically-engineered-dendritic-cell
2 · Reply
fishmedic
fishmedic Jul. 17 at 1:35 PM
$RENB this price action gives me heartburn.
0 · Reply
DARKP00L
DARKP00L Jul. 17 at 1:24 PM
$RENB momentum building! Stock attracting attention, could be a mover!
0 · Reply
ATerragna
ATerragna Jul. 17 at 1:19 PM
$RENB Is this ready?
0 · Reply
Marketmoverjoe
Marketmoverjoe Jul. 17 at 10:01 AM
$RENB of course I sold yesterday when they were up 6% and it runs to 23% Tired of watching this thing go up and down. Go get em, boyz.
0 · Reply
BALLER808
BALLER808 Jul. 16 at 9:31 PM
0 · Reply
1dk2la
1dk2la Jul. 16 at 7:07 PM
$RENB volume and 20% gain is obviously trending great. No messages on the board is interesting. Are all the long holding their breath like me !?
2 · Reply
paok44
paok44 Jul. 16 at 2:00 PM
$RENB One thing is for sure, the whole drop was for the debt bond that was issued. We have something good today, maybe we saw the lows for this year. Let's see!!!!!
0 · Reply
Aristoteli
Aristoteli Jul. 15 at 10:44 PM
$RENB dead
1 · Reply
ThebookofEli
ThebookofEli Jul. 15 at 8:12 PM
$RENB looks good, reverse split probably coming soon
1 · Reply
11thestate
11thestate Jul. 15 at 1:23 PM
$RENB reached a settlement with $ENOB investors over claims that it concealed its co-founder’s lack of proper credentials and criminal history. Who’s eligible? Anyone who bought and held $ENOB stock between January 17, 2018, and June 27, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold your shares. How much is the payout? Estimated at $0.09 per share — but if only ~25% of eligible investors file, the effective payout could increase to $0.36 per share. Can I still file? Yes — late claims are currently being considered, pending court approval. When do payouts happen? The payout timeline will be announced after the court finalizes the settlement terms. To file your claim: https://11th.com/cases/enochian-biosciences-investor-settlement
0 · Reply
paok44
paok44 Jul. 15 at 12:54 PM
$RENB The conclusion is one and only!! They dropped the stock below $0.30 to issue a debt bond so that the buyer would have a large profit margin!!!
1 · Reply
MGeronimo
MGeronimo Jul. 14 at 4:55 PM
$RENB ADDED ST .72 on the dip
0 · Reply
paok44
paok44 Jul. 12 at 5:43 AM
$RENB Can someone explain to us what this is?? thanks https://d18rn0p25nwr6d.cloudfront.net/CIK-0001527728/b0739e05-05b1-41b5-95a8-e9fd02afd3ca.pdf
2 · Reply
Aristoteli
Aristoteli Jul. 11 at 6:46 PM
$RENB not good today maybe a new low or will recover sceptical bearish
1 · Reply
mogluk
mogluk Jul. 11 at 4:15 PM
$RENB Short Interest % Float 1.04 % - source: NASDAQ (short interest), Capital IQ (float)
0 · Reply
paok44
paok44 Jul. 11 at 3:34 PM
$RENB new 52 Week Low
1 · Reply